Company Profile

Taxon Biosciences Inc
Profile last edited on: 5/14/19      CAGE: 37YU7      UEI:

Business Identifier: Utilizing microbiome discovery to develop biological crop products
Year Founded
2000
First Award
2004
Latest Award
2005
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3152 Paradise Drive
Tiburon, CA 94920
   (415) 435-5116
   contact@taxon.com
   www.taxon.com
Location: Single
Congr. District: 02
County: Marin

Public Profile

Acquired by Dupont in April 2015, Taxon Biosciences had been an early stage biotechnology company in the industrial microbiome space - using genomics tools to profile microbial communities in a variety of environmental settings. Developing microbial structures for transformative apps in the agriculture, life sciences, and oil and gas industries, the firm's mission had been defined as leveraging the ability to understand microbial community structure and function to provide solutions to real world problems in markets as diverse as the energy sector and clinical diagnostics. Taxon Biosciences utilized a variety of technologies to explore microbial diversity. The general strategy had been to perform deep diversity profiles of well selected sites. Specific DNA sequences were then identified that correlated with any parameters of interest that characterize the sites such as low molecular weight gas, salinity, etc. Rapid and quantitative assays for these indicator species are then developed for use in large area Bioindicator Surveys.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2005 2 DOE $849,568
Project Title: SARD: a Novel Surveying Method to Develop Genomic Reagents

Key People / Management

  Gelnn E Nedwin -- CEO

  Matthew Ashby -- CSO and Founder

  Chris Belnap -- Senior Scientist

  Dago F Dimster-Denk

  Jasper Rine -- Founder and Chair

  Stewart Scherer -- Founder